Oakridge International Limited (U9O0.F)
EUR 0.03
(36.36%)
EUR 0.03
(36.36%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.04 AUD | -533.82% |
| 2023 | -0.01 AUD | 77.99% |
| 2022 | -0.03 AUD | -151.5% |
| 2021 | 0.06 AUD | 591.8% |
| 2020 | -0.01 AUD | 7.58% |
| 2019 | -0.01 AUD | 98.48% |
| 2018 | -0.87 AUD | 42.38% |
| 2017 | -1.51 AUD | -155.93% |
| 2016 | -0.59 AUD | 56.93% |
| 2015 | -1.37 AUD | -153.7% |
| 2014 | -0.54 AUD | 94.68% |
| 2013 | -10.15 AUD | 91.91% |
| 2012 | -125.42 AUD | -930.57% |
| 2011 | -12.17 AUD | 51.38% |
| 2010 | -25.03 AUD | -21.09% |
| 2009 | -20.67 AUD | 47.15% |
| 2008 | -39.11 AUD | 90.49% |
| 2007 | -411.35 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.02 EUR | 0.0% |
| 2024 Q4 | -0.01 EUR | 0.0% |
| 2023 FY | - AUD | 77.99% |
| 2023 Q4 | 0.00 EUR | 125.86% |
| 2023 Q2 | -0.01 EUR | -18.37% |
| 2022 Q2 | -0.02 EUR | -50.0% |
| 2022 Q4 | -0.00 EUR | 67.33% |
| 2022 FY | - AUD | -151.5% |
| 2021 FY | - AUD | 591.8% |
| 2021 Q4 | -0.01 EUR | -121.69% |
| 2021 Q2 | 0.05 EUR | 234.8% |
| 2020 Q2 | 0.03 EUR | 112.95% |
| 2020 Q4 | -0.03 EUR | -220.0% |
| 2020 FY | - AUD | 7.58% |
| 2019 Q4 | -0.22 EUR | 0.0% |
| 2019 FY | - AUD | 98.48% |
| 2018 FY | - AUD | 42.38% |
| 2017 FY | - AUD | -155.93% |
| 2016 FY | - AUD | 56.93% |
| 2015 FY | - AUD | -153.7% |
| 2014 FY | - AUD | 94.68% |
| 2013 FY | - AUD | 91.91% |
| 2012 FY | - AUD | -930.57% |
| 2011 FY | - AUD | 51.38% |
| 2010 FY | - AUD | -21.09% |
| 2009 FY | - AUD | 47.15% |
| 2008 FY | - AUD | 90.49% |
| 2007 FY | - AUD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| DocCheck AG | 0.45 EUR | 109.578% |
| CompuGroup Medical SE & Co. KGaA | 0.88 EUR | 104.898% |
| MeVis Medical Solutions AG | 2.70 EUR | 101.596% |
| Nexus AG | 1.39 EUR | 103.101% |